Role of Microorganisms in Drug Development: A Comprehensive Review

Authors

  • karan kshitij , NIMS University Rajasthan, Jaipur, India.
  • Arushi Tyagi NIMS University Rajasthan, Jaipur, India.
  • Aarti khuswah NIMS University Rajasthan, Jaipur, India.

Abstract

Microorganisms play a pivotal role in various stages of drug development, contributing to the discovery, production, and testing of pharmaceuticals. It provides an extensive examination of the multifaceted interactions between microorganisms and drug development processes. From natural product discovery to fermentation-based production and microbiome research, microorganisms influence drug development significantly. Understanding these microbial contributions is crucial for advancing drug development strategies and fostering innovation
in the pharmaceutical industry.

How to cite this article:

Kshitij K, Tyagi A, khuswah A. Role of
Microorganisms in Drug Development: A
Comprehensive Review. J Durg Dis Dev 2023;
7(2): 27-31.

References

Brown ED, Wright GD. Antibacterial resistance: the good, the bad, and the ugly. Trends in Microbiology. 2016;24(6): 413-415.

Lewis K. Platforms for antibiotic discovery. Nature Reviews Drug Discovery. 2013;12(5): 371-387.

Walsh C. Where will new antibiotics come from? Nature Reviews Microbiology. 2003;1(1): 65-70.

Wright GD. Antibiotic adjuvants: rescuing antibiotics from resistance. Trends in Microbiology. 2016;24(11): 862-871.

Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews. 2010;74(3): 417-433.

Clardy J, Fischbach MA, Walsh CT. New antibiotics from bacterial natural products. Nature Biotechnology. 2006;24(12): 1541-1550.

Butler MS, Blaskovich MA, Cooper MA. Antibiotics in the clinical pipeline at the end of 2015. The Journal of Antibiotics. 2017;70(1): 3-24.

Piddock LJ. Reflecting on the final report of the O’Neill Review on Antimicrobial Resistance. The Lancet Infectious Diseases. 2016;16(7): 767-768.

Projan SJ. Why is big Pharma getting out of antibacterial drug discovery? Current Opinion in Microbiology. 2003;6(5): 427-430.

Berdy J. Thoughts and facts about antibiotics: where we are now and where we are heading. Journal of Antibiotics. 2012;65(8): 385-395.

Demain AL, Sanchez S. Microbial drug discovery: 80 years of progress. The Journal of Antibiotics. 2009;62(1): 5-16.

Challis GL. Genome mining for novel natural product discovery. Journal of Medicinal Chemistry. 2008;51(9): 2618-2628.

Genilloud O. Actinomycetes: still a source of novel antibiotics. Nature Reviews Microbiology. 2017;15(7): 401-413.

Walsh CT, Wencewicz TA. Prospects for new antibiotics: a molecule-centered perspective. Journal of Antibiotics. 2014;67(1): 7-22.

Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and Therapeutics. 2015;40(4): 277-283.

Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, et al. A new antibiotic kills pathogens without detectable resistance. Nature. 2015;517(7535): 455-459.

Wright GD. The antibiotic resistome: the nexus of chemical and genetic diversity. Nature Reviews Microbiology. 2007;5(3): 175-186.

Fischbach MA, Walsh CT. Antibiotics for emerging pathogens. Science. 2009;325(5944): 1089-1093.

Downloads

Published

2023-12-30

How to Cite

kshitij, karan, Arushi Tyagi, & Aarti khuswah. (2023). Role of Microorganisms in Drug Development: A Comprehensive Review. Journal of Drug Discovery and Development ( ISSN:2581-6861), 7(2), 27-31. Retrieved from http://medicaljournalshouse.com/index.php/JDrug-Discovery-Development/article/view/1087